PCDPrivate Comps Data

Company record · updated August 5, 2026

Omada Health, Inc.: 7 valuation observations from SEC filings

Every row below names the filing it came from. Coverage for this company runs May 9, 2025 to May 9, 2025.

7observations
1source filings
7verified rows
2025-05-09most recent as-of date

Source rails for this company: S-1 charter round (7).

As ofMeasureValueReported byTier What the filing saysAccession
2025-05-09 Series E price per share 5.9952 USD VERIFIED "Original Issue Price" defined for Series E 000119312525116907
2025-05-09 Series D-1 price per share 5.9952 USD VERIFIED "Original Issue Price" defined for Series D-1 000119312525116907
2025-05-09 Series D price per share 5.0365 USD VERIFIED "Original Issue Price" defined for Series D 000119312525116907
2025-05-09 Series C-1 price per share 3.7423 USD VERIFIED "Original Issue Price" defined for Series C-1 000119312525116907
2025-05-09 Series C price per share 3.1631 USD VERIFIED "Original Issue Price" defined for Series C 000119312525116907
2025-05-09 Series B price per share 1.1828 USD VERIFIED "Original Issue Price" defined for Series B 000119312525116907
2025-05-09 Series A price per share 0.5342 USD VERIFIED "Original Issue Price" defined for Series A 000119312525116907

Reading these figures

A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.